US regulators let company test consumers for health risks


It is the first direct-to-consumer genetic test the FDA has allowed to provide that information. The tests will be tentatively available to the general public in April, 2017.

The FDA said the tests are meant to provide genetic risk information but can not determine a person's overall risk of developing a disease or condition. In addition, this may nudge them to make key changes in their lifestyle choices to minimize the incidence of these diseases. Test results should not be used to diagnose or treat a specific illness, the agency added.

Americans may soon be sidestepping their doctors with an at-home DNA test by 23andMe that determines genetic risks for diseases like late-onset Alzheimer's and Parkinson's, thanks to a historic approval by the FDA.

WrestleMania 33 - Brock Lesnar defeats Goldberg to win Universal Championship
For hard-core wrestling fans, the match-up between Kevin Owens and Chris Jericho will be the highlight of Sunday's Wrestlemania. I predict that Jericho, who will tie Bret Hart for sixth place all-time by wrestling in his 14th Mania match , will lose.

The company's genetic health risk reports (GHR) work by testing saliva samples for more than 500,000 genetic variants whose presence or absence may be associated with the conditions approved by the FDA.

By establishing special controls and a pre-market review exemption, "the FDA can provide a streamlined, flexible approach for tests using similar technologies to enter the market while the agency continues to help ensure that they provide accurate and reproducible results", Shuren said.

"But, it is important that people understand that genetic risk is just one piece of the bigger puzzle".

Xbox Project Scorpio Price Could Be $499 Based on Specs
AMD's Radeon RX 480 contains 36 cores that hum along between 1,120 MHz and 1,266 MHz. The GPU is paired with 12GB of fast GDDR5 memory and a custom eight-core CPU .

The test can not give a full picture of a person's overall risk for diseases, because it does not account for environmental or lifestyle factors as well as every single genetic variant.

The development has opened the door to the development of special controls, envisaged by the FDA, pertaining to ascertaining the tests' accuracy, reliability, and clinical relevance. It said it may also exempt such tests from other companies that meet preliminary expectations.

The U.S. National Human Genome Research Institute has more on genetic testing.

Should Trump Go To Prison? Rep
Of course, by Trump's standards, "The O'Reilly Factor" host is a tremendous guy, maybe even the most tremendous person he knows. O'Reilly's comments resulted in a backlash and he ultimately apologized, saying that his comment on Waters' hair was "dumb".

In 2015 the FDA gave approval to 23andMe to test for mutated genes that may lead to diseases such as cystic fibrosis in children.